Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
A full-size, high-density RNA microchip is about the size of a fingernail and can contain up to 780 000 unique RNA sequences, each occupying a ~14 x 14 μm² area. The presence and the quality of the ...
Chief technology officer Don Montgomery explains that CombiMatrix's system synthesizes oligonucleotide probes directly on the chip through electrochemical methods. As a result, no mechanical parts are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback